3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
20
Lymphoma
6
Lymphoma, T-Cell, Peripheral
5
Lymphoma, T-Cell
5
Mycosis Fungoides
4
Lymphoma, T-Cell, Cutaneous
4
Lymphomatoid Papulosis
3
Lymphoma, Large-Cell, Anaplastic
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Lymphoma, Primary Cutaneous Anaplastic Large Cell
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Immunoblastic Lymphadenopathy
2
Hematologic Diseases
2
Enteropathy-Associated T-Cell Lymphoma
2
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Extranodal NK-T-Cell
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Valganciclovir
3
Rituximab
3
Cisplatin
3
Vincristine
2
Radiotherapy, Intensity-Modulated
2
Prednisone
2
Matrix-M
2
Gemcitabine
2
Etoposide
2
Doxorubicin
2
Cyclophosphamide
2
pomalidomide
1
dehydroftorafur
1
brincidofovir
1
Watchful Waiting
1
Valacyclovir
1
Tomography, X-Ray Computed
1
Tenofovir
1
Tegafur
1
Taxes
1
Platinum
1
Phantoms, Imaging
1
Paclitaxel
1
Nivolumab
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Interferons
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Epstein-Barr Virus Infections
×
Brentuximab Vedotin
×
1 year
×
Clear all
No trials found.